Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice

Yohei Kawakami, William S. Hambright, Koji Takayama, Xiaodong Mu, Aiping Lu, James H. Cummins, Tomoyuki Matsumoto, Takashi Yurube, Ryosuke Kuroda, Masahiro Kurosaka, Freddie H. Fu, Paul D. Robbins, Laura J. Niedernhofer, Johnny Huard

Research output: Contribution to journalArticle

Abstract

Aging-related loss of adult stem cell function contributes to impaired tissue regeneration. Mice deficient in zinc metalloproteinase STE24 (Zmpste24−/−) exhibit premature age-related musculoskeletal pathologies similar to those observed in children with Hutchinson-Gilford progeria syndrome (HGPS). We have reported that muscle-derived stem/progenitor cells (MDSPCs) isolated from Zmpste24−/− mice are defective in their proliferation and differentiation capabilities in culture and during tissue regeneration. The mechanistic target of rapamycin complex 1 (mTORC1) regulates cell growth, and inhibition of the mTORC1 pathway extends the lifespan of several animal species. We therefore hypothesized that inhibition of mTORC1 signaling would rescue the differentiation defects observed in progeroid MDSPCs. MDSPCs were isolated from Zmpste24−/− mice, and the effects of mTORC1 on MDSPC differentiation and function were examined. We found that mTORC1 signaling was increased in senescent Zmpste24−/− MDSPCs, along with impaired chondrogenic, osteogenic, and myogenic differentiation capacity versus wild-type MDSPCs. Interestingly, we observed that mTORC1 inhibition with rapamycin improved myogenic and chondrogenic differentiation and reduced levels of apoptosis and senescence in Zmpste24−/− MDSPCs. Our results demonstrate that age-related adult stem/progenitor cell dysfunction contributes to impaired regenerative capacities and that mTORC1 inhibition may represent a potential therapeutic strategy for improving differentiation capacities of senescent stem and muscle progenitor cells.

Original languageEnglish (US)
Pages (from-to)64-76
Number of pages13
JournalMolecular Therapy - Methods and Clinical Development
Volume14
DOIs
StatePublished - Sep 13 2019

Fingerprint

Sirolimus
Stem Cells
Muscles
Metalloproteases
Zinc
Adult Stem Cells
Regeneration
Progeria
mechanistic target of rapamycin complex 1
Muscle Cells
Cell Differentiation

Keywords

  • MDSPC
  • mTORC1
  • multipotent differentiation
  • muscle regeneration
  • rapamycin
  • vaging

PubMed: MeSH publication types

  • Journal Article

Cite this

Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice. / Kawakami, Yohei; Hambright, William S.; Takayama, Koji; Mu, Xiaodong; Lu, Aiping; Cummins, James H.; Matsumoto, Tomoyuki; Yurube, Takashi; Kuroda, Ryosuke; Kurosaka, Masahiro; Fu, Freddie H.; Robbins, Paul D.; Niedernhofer, Laura J.; Huard, Johnny.

In: Molecular Therapy - Methods and Clinical Development, Vol. 14, 13.09.2019, p. 64-76.

Research output: Contribution to journalArticle

Kawakami, Y, Hambright, WS, Takayama, K, Mu, X, Lu, A, Cummins, JH, Matsumoto, T, Yurube, T, Kuroda, R, Kurosaka, M, Fu, FH, Robbins, PD, Niedernhofer, LJ & Huard, J 2019, 'Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice', Molecular Therapy - Methods and Clinical Development, vol. 14, pp. 64-76. https://doi.org/10.1016/j.omtm.2019.05.011
Kawakami, Yohei ; Hambright, William S. ; Takayama, Koji ; Mu, Xiaodong ; Lu, Aiping ; Cummins, James H. ; Matsumoto, Tomoyuki ; Yurube, Takashi ; Kuroda, Ryosuke ; Kurosaka, Masahiro ; Fu, Freddie H. ; Robbins, Paul D. ; Niedernhofer, Laura J. ; Huard, Johnny. / Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice. In: Molecular Therapy - Methods and Clinical Development. 2019 ; Vol. 14. pp. 64-76.
@article{29e9ee4ab32148c3b60b48bb078d02fc,
title = "Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice",
abstract = "Aging-related loss of adult stem cell function contributes to impaired tissue regeneration. Mice deficient in zinc metalloproteinase STE24 (Zmpste24−/−) exhibit premature age-related musculoskeletal pathologies similar to those observed in children with Hutchinson-Gilford progeria syndrome (HGPS). We have reported that muscle-derived stem/progenitor cells (MDSPCs) isolated from Zmpste24−/− mice are defective in their proliferation and differentiation capabilities in culture and during tissue regeneration. The mechanistic target of rapamycin complex 1 (mTORC1) regulates cell growth, and inhibition of the mTORC1 pathway extends the lifespan of several animal species. We therefore hypothesized that inhibition of mTORC1 signaling would rescue the differentiation defects observed in progeroid MDSPCs. MDSPCs were isolated from Zmpste24−/− mice, and the effects of mTORC1 on MDSPC differentiation and function were examined. We found that mTORC1 signaling was increased in senescent Zmpste24−/− MDSPCs, along with impaired chondrogenic, osteogenic, and myogenic differentiation capacity versus wild-type MDSPCs. Interestingly, we observed that mTORC1 inhibition with rapamycin improved myogenic and chondrogenic differentiation and reduced levels of apoptosis and senescence in Zmpste24−/− MDSPCs. Our results demonstrate that age-related adult stem/progenitor cell dysfunction contributes to impaired regenerative capacities and that mTORC1 inhibition may represent a potential therapeutic strategy for improving differentiation capacities of senescent stem and muscle progenitor cells.",
keywords = "MDSPC, mTORC1, multipotent differentiation, muscle regeneration, rapamycin, vaging",
author = "Yohei Kawakami and Hambright, {William S.} and Koji Takayama and Xiaodong Mu and Aiping Lu and Cummins, {James H.} and Tomoyuki Matsumoto and Takashi Yurube and Ryosuke Kuroda and Masahiro Kurosaka and Fu, {Freddie H.} and Robbins, {Paul D.} and Niedernhofer, {Laura J.} and Johnny Huard",
year = "2019",
month = "9",
day = "13",
doi = "10.1016/j.omtm.2019.05.011",
language = "English (US)",
volume = "14",
pages = "64--76",
journal = "Molecular Therapy - Methods and Clinical Development",
issn = "2329-0501",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice

AU - Kawakami, Yohei

AU - Hambright, William S.

AU - Takayama, Koji

AU - Mu, Xiaodong

AU - Lu, Aiping

AU - Cummins, James H.

AU - Matsumoto, Tomoyuki

AU - Yurube, Takashi

AU - Kuroda, Ryosuke

AU - Kurosaka, Masahiro

AU - Fu, Freddie H.

AU - Robbins, Paul D.

AU - Niedernhofer, Laura J.

AU - Huard, Johnny

PY - 2019/9/13

Y1 - 2019/9/13

N2 - Aging-related loss of adult stem cell function contributes to impaired tissue regeneration. Mice deficient in zinc metalloproteinase STE24 (Zmpste24−/−) exhibit premature age-related musculoskeletal pathologies similar to those observed in children with Hutchinson-Gilford progeria syndrome (HGPS). We have reported that muscle-derived stem/progenitor cells (MDSPCs) isolated from Zmpste24−/− mice are defective in their proliferation and differentiation capabilities in culture and during tissue regeneration. The mechanistic target of rapamycin complex 1 (mTORC1) regulates cell growth, and inhibition of the mTORC1 pathway extends the lifespan of several animal species. We therefore hypothesized that inhibition of mTORC1 signaling would rescue the differentiation defects observed in progeroid MDSPCs. MDSPCs were isolated from Zmpste24−/− mice, and the effects of mTORC1 on MDSPC differentiation and function were examined. We found that mTORC1 signaling was increased in senescent Zmpste24−/− MDSPCs, along with impaired chondrogenic, osteogenic, and myogenic differentiation capacity versus wild-type MDSPCs. Interestingly, we observed that mTORC1 inhibition with rapamycin improved myogenic and chondrogenic differentiation and reduced levels of apoptosis and senescence in Zmpste24−/− MDSPCs. Our results demonstrate that age-related adult stem/progenitor cell dysfunction contributes to impaired regenerative capacities and that mTORC1 inhibition may represent a potential therapeutic strategy for improving differentiation capacities of senescent stem and muscle progenitor cells.

AB - Aging-related loss of adult stem cell function contributes to impaired tissue regeneration. Mice deficient in zinc metalloproteinase STE24 (Zmpste24−/−) exhibit premature age-related musculoskeletal pathologies similar to those observed in children with Hutchinson-Gilford progeria syndrome (HGPS). We have reported that muscle-derived stem/progenitor cells (MDSPCs) isolated from Zmpste24−/− mice are defective in their proliferation and differentiation capabilities in culture and during tissue regeneration. The mechanistic target of rapamycin complex 1 (mTORC1) regulates cell growth, and inhibition of the mTORC1 pathway extends the lifespan of several animal species. We therefore hypothesized that inhibition of mTORC1 signaling would rescue the differentiation defects observed in progeroid MDSPCs. MDSPCs were isolated from Zmpste24−/− mice, and the effects of mTORC1 on MDSPC differentiation and function were examined. We found that mTORC1 signaling was increased in senescent Zmpste24−/− MDSPCs, along with impaired chondrogenic, osteogenic, and myogenic differentiation capacity versus wild-type MDSPCs. Interestingly, we observed that mTORC1 inhibition with rapamycin improved myogenic and chondrogenic differentiation and reduced levels of apoptosis and senescence in Zmpste24−/− MDSPCs. Our results demonstrate that age-related adult stem/progenitor cell dysfunction contributes to impaired regenerative capacities and that mTORC1 inhibition may represent a potential therapeutic strategy for improving differentiation capacities of senescent stem and muscle progenitor cells.

KW - MDSPC

KW - mTORC1

KW - multipotent differentiation

KW - muscle regeneration

KW - rapamycin

KW - vaging

UR - http://www.scopus.com/inward/record.url?scp=85068042182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068042182&partnerID=8YFLogxK

U2 - 10.1016/j.omtm.2019.05.011

DO - 10.1016/j.omtm.2019.05.011

M3 - Article

C2 - 31312666

AN - SCOPUS:85068042182

VL - 14

SP - 64

EP - 76

JO - Molecular Therapy - Methods and Clinical Development

JF - Molecular Therapy - Methods and Clinical Development

SN - 2329-0501

ER -